Stallergenes Greer
stallergenesgreer.comLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
26
Active
0
Phase 3
12
Total enrollment
12,904
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Allergy8
- Rhinitis, Allergic, Seasonal4
- Allergic Rhinitis3
- House Dust Mite Allergy3
- Birch Pollen-Related Rhinoconjunctivitis2
- Allergic Rhinitis Due to House Dust Mite2
- Allergic Rhinitis Due to Grass Pollens2
- Asthma2
Frequently asked questions about Stallergenes Greer
- How many clinical trials does Stallergenes Greer have on ClinicalTrials.gov?
- Stallergenes Greer is listed as the lead sponsor on 26 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Stallergenes Greer's trials are in Phase 3?
- 12 of Stallergenes Greer's trials are in Phase 3.
- What therapeutic areas does Stallergenes Greer focus on?
- Stallergenes Greer's most-studied conditions on ClinicalTrials.gov are Allergy, Rhinitis, Allergic, Seasonal, Allergic Rhinitis, House Dust Mite Allergy, Birch Pollen-Related Rhinoconjunctivitis.